Search
Now showing items 31-40 of 449
Curcumin and paclitaxel induce cell death in breast cancer cell lines
(Spandidos Publications, 2018)
Breast cancer is one of the major health issues confronting women; however, treatment with conventional chemotherapeutic drugs is limited. Currently, paclitaxel is used as a therapeutic clinical agent to treat breast cancer ...
Curcumin and paclitaxel induce cell death in breast cancer cell lines
(2018)
Breast cancer is one of the major health issues confronting women; however, treatment with conventional chemotherapeutic drugs is limited. Currently, paclitaxel is used as a therapeutic clinical agent to treat breast cancer ...
Suicide HSVtk Gene Delivery by Neurotensin-Polyplex Nanoparticles via the Bloodstream and GCV Treatment Specifically Inhibit the Growth of Human MDA-MB-231 Triple Negative Breast Cancer Tumors Xenografted in Athymic Mice
(Public Library of Science, 2014)
The human breast adenocarcinoma cell line MDA-MB-231 has the triple-negative breast cancer (TNBC) phenotype, which is an aggressive subtype with no specific treatment. MDA-MB-231 cells express neurotensin receptor type 1 ...
Suicide HSVtk Gene Delivery by Neurotensin-Polyplex Nanoparticles via the Bloodstream and GCV Treatment Specifically Inhibit the Growth of Human MDA-MB-231 Triple Negative Breast Cancer Tumors Xenografted in Athymic Mice
(Public Library of Science, 2014)
The human breast adenocarcinoma cell line MDA-MB-231 has the triple-negative breast cancer (TNBC) phenotype, which is an aggressive subtype with no specific treatment. MDA-MB-231 cells express neurotensin receptor type 1 ...
Resultados del tratamiento del cáncer de mama, Programa Nacional de Cáncer del Adulto
(Sociedad Médica de Santiago, 2017)
Background: Breast cancer is the most common malignant tumor in women
in the world. In 2005, it was incorporated to the Explicit Guaranties Health
System (GES) in Chile. Aim: To describe the demographic and clinical ...
Resultados del tratamiento del cáncer de mama, Programa Nacional de Cáncer del Adulto
(Sociedad Médica Santiago, 2017)
Background: Breast cancer is the most common malignant tumor in women
in the world. In 2005, it was incorporated to the Explicit Guaranties Health
System (GES) in Chile. Aim: To describe the demographic and clinical ...
Effect of CCL5 expression in the recruitment of immune cells in triple negative breast cancer
(Scientific ReportsPE, 2018)
Triple negative breast cancer (TNBC) is the most aggressive form of breast cancer with limited options
of targeted therapy. Recent findings suggest that the clinical course of TNBC may be modified by the
presence of ...
Inhibition of the AnxA1/FPR1 autocrine axis reduces MDA-MB-231 breast cancer cell growth and aggressiveness in vitro and in vivo
(2018-09-01)
Breast Cancer (BC) is a highly heterogeneous disease whose most aggressive behavior is displayed by triple-negative breast cancer (TNBC), which lacks an efficient targeted therapy. Despite its controversial role, one of ...
Terapias target más Quimioterapia comparado con Quimioterapia en Cáncer de mama triple negativo EC IV o recurrente. Revisión Sistemática y Metaanálisis
(Universidad Privada Antenor OrregoPE, 2021)
El cáncer de mama es el tumor maligno más frecuente en mujeres de
todo el mundo. Las pacientes con cáncer de mama triple negativo representan un
subgrupo de pronóstico desfavorable sobre todo en etapas avanzadas de la ...